Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

FNCHQ

Finch Therapeutics Group, Inc.

USD

Set alert

Price alert · FNCHQ

All alert types
10.35 USD 0.00 0.00%
As of Sep 30, 2026
7.00 Day range 10.35
2.00 52-week range 16.10
YTD
+7.81%
1 year
+7.81%
Open
7.75
Prev close
10.35
Mkt cap
16.62M
Vol
600
Avg vol
1.10K
EPS
-6.92
P/E
-1.50
More statistics
Low
7.00
High
10.35

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for FNCHQ has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-11.74 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -1.3×
FY 2019: -1516×FY 2020: -788×FY 2021: -245×FY 2022: -6.0×FY 2023: -0.1×FY 2024: -1.3×
FY 2019 5y median -6.0× FY 2024
P/S 0.0×
FY 2019: 3047×FY 2020: 4008×FY 2021: 768×FY 2022: 799×FY 2023: 54.1×FY 2024: 0.0×
FY 2019 5y median 768× FY 2024
P/B 2.0×
FY 2019: -520×FY 2020: -323×FY 2021: 70.4×FY 2022: 7.2×FY 2023: 0.3×FY 2024: 2.0×
FY 2019 5y median 2.0× FY 2024
P/FCF 0.0×
FY 2019: -1688×FY 2020: -911×FY 2021: -171×FY 2022: -8.9×FY 2023: -0.2×FY 2024: 0.0×
FY 2019 5y median -8.9× FY 2024
EV/EBITDA -2.6×
FY 2019: -1502×FY 2020: -798×FY 2021: -245×FY 2022: -8.1×FY 2023: -0.3×FY 2024: -2.6×
FY 2019 5y median -8.1× FY 2024
EV/Sales 0.0×
FY 2019: 3057×FY 2020: 3995×FY 2021: 762×FY 2022: 778×FY 2023: 101×FY 2024: 0.0×
FY 2019 5y median 762× FY 2024
FCF Yield 0.0%
FY 2019: -0.1%FY 2020: -0.1%FY 2021: -0.6%FY 2022: -11.2%FY 2023: -543.9%FY 2024: 0.0%
FY 2019 5y median -0.6% FY 2024

Profitability

Gross Margin 0.0%
FY 2019: 96.9%FY 2020: -329.4%FY 2021: -209.1%FY 2022: -539.6%FY 2023: -1320.6%FY 2024: 0.0%
FY 2019 5y median -329.4% FY 2024
Operating Margin 0.0%
FY 2019: -208.2%FY 2020: -510.9%FY 2021: -323.7%FY 2022: -11047.6%FY 2023: -31777.6%FY 2024: 0.0%
FY 2019 5y median -510.9% FY 2024
Net Margin 0.0%
FY 2019: -204.4%FY 2020: -508.5%FY 2021: -313.8%FY 2022: -13315.4%FY 2023: -69863.6%FY 2024: 0.0%
FY 2019 5y median -508.5% FY 2024
ROE -152.8%
FY 2019: 34.9%FY 2020: 41.0%FY 2021: -28.8%FY 2022: -119.8%FY 2023: -326.6%FY 2024: -152.8%
FY 2019 5y median -119.8% FY 2024
ROIC -38.6%
FY 2019: -22.0%FY 2020: -25.6%FY 2021: -27.2%FY 2022: -62.7%FY 2023: -61.3%FY 2024: -38.6%
FY 2019 5y median -38.6% FY 2024
ROA -27.9%
FY 2019: -20.0%FY 2020: -23.7%FY 2021: -25.8%FY 2022: -70.4%FY 2023: -135.0%FY 2024: -27.9%
FY 2019 5y median -27.9% FY 2024

Growth (YoY)

Revenue -100.0%
FY 2019: 0.0%FY 2020: -24.0%FY 2021: 140.1%FY 2022: -95.4%FY 2023: -87.6%FY 2024: -100.0%
FY 2019 FY 2024
Operating Income 44.5%
FY 2019: 0.0%FY 2020: -86.5%FY 2021: -52.1%FY 2022: -58.6%FY 2023: 64.3%FY 2024: 44.5%
FY 2019 FY 2024
EPS (diluted) 81.5%
FY 2019: 0.0%FY 2020: -92.4%FY 2021: -50.6%FY 2022: -96.4%FY 2023: 35.4%FY 2024: 81.5%
FY 2019 FY 2024
Free Cash Flow 0.0%
FY 2019: 0.0%FY 2020: -85.3%FY 2021: -144.7%FY 2022: 7.3%FY 2023: 59.1%FY 2024: 0.0%
FY 2019 FY 2024

Financial Health

Current Ratio 3.4×
FY 2019: 6.6×FY 2020: 9.2×FY 2021: 9.6×FY 2022: 4.8×FY 2023: 6.3×FY 2024: 3.4×
FY 2019 5y median 6.3× FY 2024
Quick Ratio 3.4×
FY 2019: 6.6×FY 2020: 9.2×FY 2021: 10.3×FY 2022: 5.1×FY 2023: 6.3×FY 2024: 3.4×
FY 2019 5y median 6.3× FY 2024
Debt / Equity 3.1×
FY 2019: -2.4×FY 2020: -0.0×FY 2021: 0.1×FY 2022: 0.5×FY 2023: 1.3×FY 2024: 3.1×
FY 2019 5y median 0.5× FY 2024
Net Debt / EBITDA -1.3×
FY 2019: -4.9×FY 2020: 2.5×FY 2021: 2.1×FY 2022: 0.2×FY 2023: -0.2×FY 2024: -1.3×
FY 2019 5y median 0.2× FY 2024
Interest Coverage 0.0×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2019 5y median 0.0× FY 2024

Dividends

Dividend Yield 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2019 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2019 5y median 0.0% FY 2024

Annual · latest fiscal year ends 2024-12-31